Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 17, 2020

SELL
$60.41 - $115.92 $76.5 Million - $147 Million
-1,266,376 Closed
0 $0
Q3 2019

Oct 24, 2019

BUY
$16.05 - $27.35 $20.3 Million - $34.6 Million
1,266,376 New
1,266,376 $20.6 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust Portfolio

Follow Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust, based on Form 13F filings with the SEC.

News

Stay updated on Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust with notifications on news.